CW July 2003
Volume 12Issue Number 7 July 2003 ISSN 10593802 Weekly Epoetin Alfa for Anemia Prevention in Advanced NSCLCWhen patients with advanced small-cell lung cancer (NSCLC) are receiving first-line chemotherapy, giving them epoetin alfa (Procrit, Ortho Biotech) once-weekly safely and effectively prevents anemia for many.
Go to Previous Page Go to Next Page Source & Additional Reading J. Crawford, 39th Annual Meeting of the American Association of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
